|
TRIP
|
Although he had experimented with psilocybin mushrooms sporadically...
|
|
V.GRAT
|
Steve Gray, P. Geo. and a Director of the Company has reviewed and approved...
|
|
V.GRAT
|
The Graphite concentrate is scheduled to leave Namibia for Toronto on October...
|
|
V.GRAT
|
Experts agree that graphite anodes will remain in use for the foreseeable...
|
|
V.GRAT
|
The pair have conducted extensive research into battery manufacturing...
|
|
V.GRAT
|
President and CEO, Arno Brand, along with COO and Head of Graphite Marketing...
|
|
C.QNTM
|
“Today, we are among a select group of 12 Canadian-domiciled, cannabis...
|
|
C.QNTM
|
“We are immensely thrilled to ring the opening bell at the CSE to celebrate...
|
|
C.QNTM
|
Through its acquisition of Prismic Pharmaceuticals in 2Q19, FSD BioSciences...
|
|
C.QNTM
|
FSD Pharma’s equity position of 13.5 million Pharmadrug shares was...
|
|
C.QNTM
|
"Our immediate plans for FSD201 include submitting these Phase 1 trial...
|
|
C.QNTM
|
Pursuant to the Settlement Agreement, the Company will pay C$5,500,000...
|
|
C.QNTM
|
"We are delighted to be reporting favorable topline findings from our...
|
|
C.QNTM
|
The study found ultramicronized PEA to be safe and well tolerated. Mild and...
|
|
C.QNTM
|
FSD's wholly-owned subsidiary, FV Pharma, is a licensed producer under...
|
|
C.QNTM
|
"Our immediate plans for FSD201 include submitting these Phase 1 trial...
|
|
C.QNTM
|
FSD Pharma acquired worldwide rights, excluding Italy and Spain, to ultra...
|
|
TRIP
|
There is, however, an uphill battle for the recreational market. Michael...
|
|
TRIP
|
The rise of these treatment options comes alongside some sobering news from...
|
|
TRIP
|
In 2018, the Food and Drug Administration first granted Compass Pathways ...
|